incobotulinumtoxinA news

All news on incobotulinumtoxinA (also known as Xeomin): plants, production capacities, investments and involved companies.

19 June 2026

Teijin: MHLW approves XEOMIN for cervical dystonia and blepharospasm

Japan expands XEOMIN label to two focal dystonias, adding to existing spasticity and sialorrhea indications.

Who will be producing incobotulinumtoxinA in the future?

Find out with chemXplore Alpha

Learn more